PURPOSE To determine the expression of angiogenic cytokines in macrophages and retinal pigment epithelium cells in choroidal neovascularization (CNV). METHODS Ten surgically-excised subfoveal CNV specimens and ten eye bank eyes with subfoveal CNV were routinely processed, serially sectioned, and immunostained for factor VIII (F8), CD68 (KP1), cytokeratin 18 (CK18), vascular endothelial growth...

background and objectives: significant progress has been made in treatment of hemophilia. ex-vivo gene therapy is going popular due to the capability of this method in using isogenic cells for genetic manipulation and reintroducing them into same host after proliferation. most gene therapy techniques use viral vectors, which usually harbor a strong and non-specific promoter (e.g. cmv early prom...

Background: the clinical polymorphism of depressive disorders, together with available data on different responses patients to treatment, motivate modern neuroscience search for models that can explain such heterogeneity. Objective: identify neurophysiological subtypes disorders. Patients and methods: 189 moderate depression in structure a episode (n = 42), recurrent 102) bipolar affective diso...

Herein, the incorporation of TiO 2 nanoparticles (NPs), SiO NPs, and their nanocomposite (STNC) to enhance optoelectronic properties hybrid poly[9,9′‐di‐ n ‐octylfluorenyl‐2,7‐diyl] (F8), poly[2‐methoxy‐5(2‐ethylhexyl)‐1,4‐phenylenevinylene)] (MEH‐PPV), poly[2‐methoxy‐5‐(3,7‐dimethyl‐octyloxy)‐1,4‐phenylenevinylene]‐end capped with dimethylphenyl (MDMO–PPV–DMP) are revealed. The tune donor (F8)...

Background and Objectives: Significant progress has been made in treatment of hemophilia. Ex-vivo gene therapy is going popular due to the capability of this method in using isogenic cells for genetic manipulation and reintroducing them into same host after proliferation. Most gene therapy techniques use viral vectors, which usually harbor a strong and non-specific promoter (e...

BACKGROUND Hemophilia A is caused by heterogeneous mutations in F8. Coagulation factor VIII (FVIII), the product of F8, is composed of multiple domains designated A1-A2-B-A3-C1-C2. FVIII is known to interact with diverse proteins, and this characteristic may be important for hemostasis. However, little is known about domain-specific functions or their specific binding partners. METHODS To det...

Increased factor VIII (FVIII) levels are a prevalent and independent risk factor for venous thromboembolism (VTE). The low density lipoprotein receptor-related protein 1 (LRP1) has been associated with FVIII catabolism. After a median of 10 years of the first thrombotic episode, we evaluated FVIII activity levels in 75 patients with VTE and high FVIII levels and in 74 healthy controls. Subseque...

BACKGROUND Hemophilia A is an X-chromosome-linked recessive bleeding disorder resulting from an F8 gene abnormality. Although various gene therapies have been attempted with the aim of eliminating the need for factor VIII replacement therapy, obstacles to their clinical application remain. OBJECTIVES We evaluated whether embryonic stem (ES) cells with a tetracycline-inducible system could sec...